{"@id":"https://bioecon.ru/technology/conjugate-vaccines-polysaccharide/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/conjugate-vaccines-polysaccharide/","json":"https://cn.bioecon.ru/api/v1/technology/conjugate-vaccines-polysaccharide/index.json"},"id":"conjugate-vaccines-polysaccharide","industries":["pharma","advanced-therapies","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/advanced-therapies/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/meihua-biological/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/pallas-biotech/","https://bioecon.ru/companies/loopworm/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/brevel/","https://bioecon.ru/companies/unibio/","https://bioecon.ru/companies/amai-proteins/"]},"maturity":9,"name":"多糖-蛋白质结合疫苗（肺炎球菌、脑膜炎球菌与Hib结合CRM197/破伤风类毒素载体平台）","regions":["us","cn","eu"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-15","entity":"who.int","kind":"official","urls":["https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/pneumococcal-disease"]},{"date":"2026-11-15","entity":"sciencedirect.com","kind":"research","urls":["https://doi.org/10.1016/j.vaccine.2021.05.093"]}],"stages":[{"n":1,"title":null},{"n":2,"title":null},{"n":3,"title":null},{"n":4,"title":null},{"n":5,"title":null}],"summary":"通过共价偶联技术将高纯度细菌荚膜多糖与免疫载体蛋白（CRM197无毒变异体或破伤风类毒素）相连接，使T细胞非依赖性抗原转变为T依赖性抗原，诱导2岁以下婴幼儿产生长效高亲和力IgG免疫记忆。","url":"/technology/conjugate-vaccines-polysaccharide/","verified":"2026-11-15"}